Associations between weight regain 5 years after RYGB and changes in PA outcomes. by Alice Bellicha (3583493)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…Treatment with Gemcitabine or Cisplatin alone decreased tumor volume to a higher (p < 0.05) extent than OCA alone. …”

Fig 5 - by Hanna Rauch (12191278)

A blocking anti-APRIL antibody decreases autoantibody serum levels. by Bertrand Huard (111620)

TPI demalonylation at K56 decreases PPP flux in CDCP1+ CSCs and is indispensable for postchemotherapeutic recurrence. by WenChao Gao (7321640)

Decrease in the number of intestinal pDCs in <i>Enpp3</i>^<i>-/-</i> mice. by Yoki Furuta (3772735)

RUE decreases expression of inflammatory cytokines through MAPK-NF-κB pathway. by Jeong Hoon Pan (844624)

Wnt signaling decreases the recruitment of RAB8a to basal bodies. by Cheng Yuan (160315)

Resveratrol decreases cell proliferation in a time and dose dependent manner. by Mehtap Kilic Eren (591048)

EtOH decreased ΔΨm in a subset of esophageal keratinocytes. by Prasanna M. Chandramouleeswaran (3176268)

The TSS diversity of a gene generally decreases with the gene expression level. by Chuan Xu (293667)

Decrease in DNA methylation level in NOR-1 and NOR-2 of <i>Q.robur</i> following treatment with 5-aza-2′-dC. by Vedrana Vičić Bočkor (610205)

HSC activation results in redistribution of LDs and is accompanied by a decrease in size. by Nicole Testerink (169448)

Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

“…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Time course of best-corrected visual acuity (BCVA) in all eyes. by Yasuyuki Sotani (20114144)

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…CRT in the recurrence group significantly decreased from 546.1 ± 117.0 μm preoperatively to 317.1 ± 46.9, 317.8 ± 55.6, 290.8 ± 33.5, 342.9 ± 82.2, 333.0 ± 84.2, and 349.8 ± 76.9 μm at 1, 3, 6, 12, 24, and 36 months postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”

The activity of platelet P2Y1, but not of P2X1 or P2Y12 receptor, continually decreases in citrated WB. by Juergen Koessler (847843)

Comparison of human measures of motor learning across the Start phase (5 first games) and the Middle phase (5 middle games) of <i>Auto Orbit</i>. by Pierre Giovanni Gianferrara (11553077)

Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis by Eric N. Ouattara (6890174)

“…Outcomes from the model included life expectancy, 10-year medical resource use, incremental cost-effectiveness ratios (ICERs) in $/year of life saved (YLS), and 5-year budget impact. We simulated people with HIV (PWH) in care (mean CD4: 259/<i>μ</i>L, SD 198/<i>μ</i>L) and transmitted cases. …”

LAP whole blood displays Increased capacity for 5-HETE and LTB₄ levels, and decreased for 12-HETE, 14-HDHA, 15-HETE and LXA₄. by Gabrielle Fredman (272178)